. Author manuscript; available in PMC: 2019 Mar 3.

Published in final edited form as: Ann Neurol. 2018 Mar 3;83(3):575–587. doi: 10.1002/ana.25180

Table 3.

Published stereotactic laser amygdalohippocampotomy series

Study	N	Age Range (y)	Mean LOS (d)	Complications	Mean Follow-up (m)	Outcomes
Curry et al.	1	16	4.0	None	12.0	Engel 1D: 1/1 (100%) Note: Patient with MTS
Willie et al. (included in this series)	13	16-64	1.5 repeat: 1.0	1 VFD 1 Acute SDH (without neuro deficit)	15.2^*	Engel 1 All: 7/13 (53.8%) MTS: 6/9 (66.7%)
Waseem et al.	7	54-67	1.6	2 Partial VFD	12.0	Engel 1: 4/5 (80.0%)
Kang et al.	20	11-66	1.2	1 VFD (superior quadrantanopsia due to an IPH) 1 transient 4^th CNP 1 Suicide	13.1	Engel 1 at 1 year: All: 4/11 (36.4%) MTS: 4/10 (40.0%)
Jermakowicz et al.	23	12-37	1 d: 75% 1 – 3 (range)^#	1 VFD (homonymous hemianopia)	22.4	Engel 1 All: 16/23 (69.6%) Non-MTS: 5/8 (62.5%) MTS: 11/15 (73.3%)
Gross et al. (this series)	58	16-67	1.4 Repeat: 1.3	3 VFD (2 superior quadrantanopsias^✝ and 1 homonymous hemianopsia after repeat SLAH) 1 acute SDH and 1 acute IPH with no neurodeficits 4 transient partial CNP (1 3^rd nerve and 3 4^th nerve^✝)	≥12	Engel 1 All: 31/58 (53.4%) Non-MTS: 5/15 (33.3%) MTS: 26/43 (60.5%)

With respect to last SLAH procedure if 12 mo outcome achieved.

Only data reported

^✝

One patient had both a superior quadrantanopsia after initial SLAH and a transient 4th nerve palsy after repeat SLAH

Abbreviations: MTS, mesial temporal sclerosis; VFD, visual field deficit; SDH, subdural hematoma; IPH, intraparenchymal hematoma; CNP, cranial nerve palsy